Skip Header

Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q64364 (CD2A2_MOUSE)

Last modified December 15, 2009. Version 74. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (2) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Cyclin-dependent kinase inhibitor 2A, isoform 3
Alternative name(s):
    p19ARF
Gene names
Name: Cdkn2a
OrganismMus musculus (Mouse)
Taxonomic identifier10090 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresGliresRodentiaSciurognathiMuroideaMuridaeMurinaeMus

Protein attributes

Sequence length169 AA.
Sequence statusComplete.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Capable of inducing cell cycle arrest in G1 and G2 phases. Acts as a tumor suppressor. Binds to MDM2 and blocks its nucleocytoplasmic shuttling by sequestering it in the nucleolus. This inhibits the oncogenic action of MDM2 by blocking MDM2-induced degradation of p53 and enhancing p53-dependent transactivation and apoptosis. Also induces G2 arrest and apoptosis in a p53-independent manner by preventing the activation of cyclin B1/CDC2 complexes. Binds to BCL6 and down-regulates BCL6-induced transcriptional repression. Binds to E2F1 and MYC and blocks their transcriptional activator activity but has no effect on MYC transcriptional repression. Binds to TOP1/TOPOI and stimulates its activity. This complex binds to rRNA gene promoters and may play a role in rRNA transcription and/or maturation. Interacts with NPM1/B23 and promotes its polyubiquitination and degradation, thus inhibiting rRNA processing. Interacts with UBE2I/UBC9 and enhances sumoylation of a number of its binding partners including MDM2 and E2F1. Binds to HUWE1 and represses its ubiquitin ligase activity. May play a role in controlling cell proliferation and apoptosis during mammary gland development. Ref.1 Ref.6 Ref.8 Ref.9 Ref.13 Ref.14 Ref.15 Ref.16 Ref.12 UniProtKB Q8N726

Subunit structure

Does not interact with cyclins, CDC2, CDK2, CDK4, CDK5 or CDK6. Binds to BCL6, E2F1, HUWE1, MDM2, MYC, NPM1/B23, TOP1/TOPOI and UBE2I/UBC9. Interacts with TBRG1. Interacts with CDKN2AIP and E4F1. Ref.8 Ref.13 Ref.14 Ref.11 Ref.17 UniProtKB Q8N726

Subcellular location

Nucleusnucleolus Ref.1 Ref.9 Ref.14 Ref.15.

Developmental stage

Not detected in 12-week virgin mammary glands. Expression increases (at protein level) six-fold during pregnancy and remains at this level during lactation. During involution, a slight increase is observed at days 2 and 8 followed by a sharp decline at day 15. Ref.12

Induction

By progesterone. Induced by activated Ras, and this requires DMTF1. Repressed by non-classical inhibitors of NF-kappa-B signaling such as doxorubicin, daunorubicin and UVC, and by the NF-kappa-B p65 subunit (RELA). Ref.15 Ref.12 Ref.10 Ref.18

Disruption phenotype

Mice lacking isoform p19ARF of Cdkn2a display delayed mammary gland involution. Ref.12

Ontologies

Keywords
   Biological processApoptosis
Cell cycle
Transcription
Transcription regulation
rRNA processing
   Cellular componentNucleus
   Coding sequence diversityAlternative splicing
   DiseaseTumor suppressor
   LigandDNA-binding
   Technical term3D-structure
Gene Ontology (GO)
   Biological processcell aging

Inferred from direct assay. Source: MGI

cell cycle arrest

Inferred from direct assay. Source: MGI

epidermis development

Inferred from mutant phenotype. Source: MGI

negative regulation of B cell proliferation

Inferred from mutant phenotype. Source: HGNC

negative regulation of cell growth Ref.11

Inferred from mutant phenotype. Source: UniProtKB

negative regulation of cyclin-dependent protein kinase activity

Inferred from direct assay. Source: MGI

negative regulation of immature T cell proliferation in the thymus

Inferred from mutant phenotype. Source: HGNC

negative regulation of mammary gland epithelial cell proliferation Ref.12

Inferred from mutant phenotype. Source: MGI

negative regulation of ubiquitin-protein ligase activity

Inferred from direct assay. Source: UniProtKB

positive regulation of DNA damage response, signal transduction by p53 class mediator

Inferred by curator. Source: UniProtKB

positive regulation of apoptosis involved in mammary gland involution Ref.12

Inferred from mutant phenotype. Source: MGI

rRNA processing

Inferred from electronic annotation. Source: UniProtKB-KW

rRNA transcription

Inferred from genetic interaction. Source: MGI

regulation of nucleocytoplasmic transport

Inferred from genetic interaction. Source: MGI

regulation of protein stability Ref.11

Inferred from mutant phenotype. Source: UniProtKB

regulation of transcription, DNA-dependent Ref.11

Inferred from direct assay. Source: MGI

somatic stem cell division

Inferred from mutant phenotype. Source: HGNC

   Cellular componentcytoplasm Ref.11

Inferred from direct assay. Source: MGI

granular component Ref.11

Inferred from direct assay. Source: UniProtKB

nucleoplasm Ref.11

Inferred from direct assay. Source: MGI

   Molecular functioncyclin-dependent protein kinase inhibitor activity

Inferred from direct assay. Source: MGI

protein binding

Inferred from physical interaction. Source: IntAct

transcription factor activity Ref.11

Inferred from direct assay. Source: MGI

ubiquitin-protein ligase inhibitor activity

Inferred from direct assay. Source: UniProtKB

Complete GO annotation...

Binary interactions

Alternative products

This entry describes 3 isoforms produced by alternative splicing. [Align] [Select]

Note: Isoform 1 and isoform 3 arise due to the use of two alternative first exons joined to a common exon 2 at the same acceptor site but in different reading frames, resulting in two completely different isoforms.
Isoform 3 Ref.1 (identifier: Q64364-1)

Also known as: p19ARF; ARF;

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 1 (identifier: P51480-1)

Also known as: p16INK4a;

The sequence of this isoform can be found in the external entry P51480-1.
Isoforms of the same protein are often annotated in two different entries if their sequences differ significantly.
Isoform 2 (identifier: P51480-2)

The sequence of this isoform can be found in the external entry P51480-2.
Isoforms of the same protein are often annotated in two different entries if their sequences differ significantly.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 169169Cyclin-dependent kinase inhibitor 2A, isoform 3
PRO_0000144182

Regions

Compositional bias3 – 168166Arg-rich

Experimental info

Mutagenesis851L → P or R: No effect on activity. Ref.7
Mutagenesis931P → S: No effect on activity. Ref.7
Mutagenesis971R → Q: No effect on activity. Ref.7
Mutagenesis105 – 1062Missing: No effect on activity. Ref.7
Mutagenesis1201A → T: No effect on activity. Ref.7

Secondary structure

..... 169
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Isoform 3 (p19ARF) (ARF) [UniParc].

Last modified November 1, 1996. Version 1.
Checksum: 644505EFE1CBF478

FASTA16919,238
        10         20         30         40         50         60 
MGRRFLVTVR IQRAGRPLQE RVFLVKFVRS RRPRTASCAL AFVNMLLRLE RILRRGPHRN 

        70         80         90        100        110        120 
PGPGDDDGQR SRSSSSAQLR CRFELRGPHY LLPPGARRSA GRLPGHAGGA ARVRGSAGCA 

       130        140        150        160 
RCLGSPAARL GPRAGTSRHR AIFAFRWVLF VFRWVVFVYR WERRPDRRA 

« Hide

Isoform 1 (p16INK4a).

See P51480.

FASTA
Isoform 2.

See P51480.

FASTA

References

« Hide 'large scale' references
[1]"Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest."
Quelle D.E., Zindy F., Ashmun R.A., Sherr C.J.
Cell 83:993-1000(1995) [PubMed: 8521522] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION.
[2]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Strain: NMRI.
Tissue: Mammary tumor.
[3]"Characterization of the murine p19ARF promoter CpG island and its methylation pattern in primary lymphomas."
Melendez B., Malumbres M., de Castro I.P., Santos J., Pellicer A., Fernandez-Piqueras J.
Carcinogenesis 21:817-821(2000) [PubMed: 10753221] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-64.
Strain: 129/SvJ.
[4]"Sequence variation and chromosomal mapping of the murine Cdkn2a tumor suppressor gene."
Herzog C.R., You M.
Mamm. Genome 8:65-66(1997) [PubMed: 9021155] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-63.
Strain: 020, 129/J, A/J, A/Wy, AKR/J, B10.A, B10.D2(58N), BALB/c, C3H/21BG, C3H/HeJ, C57BL/10SCN, C57BL/10SN, C57BL/6By, C57BL/6J, C57BR/cdJ, CBA/J, DBA/2J, HS/IBG, LP/J, LS/IBG, MA/M4J, PL/J, RF/J, Sencar, SJL/J, SM/J, ST/J and SWR/J.
Tissue: Lung.
[5]"Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1."
Inoue K., Roussel M.F., Sherr C.J.
Proc. Natl. Acad. Sci. U.S.A. 96:3993-3998(1999) [PubMed: 10097151] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-63.
Strain: 129/SvjE.
[6]"Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF."
Kamijo T., Zindy F., Roussel M.F., Quelle D.E., Downing J.R., Ashmun R.A., Grosveld G., Sherr C.J.
Cell 91:649-659(1997) [PubMed: 9393858] [Abstract]
Cited for: FUNCTION.
[7]"Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF."
Quelle D.E., Cheng M., Ashmun R.A., Sherr C.J.
Proc. Natl. Acad. Sci. U.S.A. 94:669-673(1997) [PubMed: 9012842] [Abstract]
Cited for: MUTAGENESIS OF LEU-85; PRO-93; ARG-97; 105-GLY-HIS-106 AND ALA-120.
[8]"The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53."
Pomerantz J., Schreiber-Agus N., Liegeois N.J., Silverman A., Alland L., Chin L., Potes J., Chen K., Orlow I., Lee H.-W., Cordon-Cardo C., DePinho R.A.
Cell 92:713-723(1998) [PubMed: 9529248] [Abstract]
Cited for: FUNCTION, INTERACTION WITH MDM2.
[9]"P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2."
Tao W., Levine A.J.
Proc. Natl. Acad. Sci. U.S.A. 96:6937-6941(1999) [PubMed: 10359817] [Abstract]
Cited for: FUNCTION, SUBCELLULAR LOCATION.
[10]"Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis."
Inoue K., Wen R., Rehg J.E., Adachi M., Cleveland J.L., Roussel M.F., Sherr C.J.
Genes Dev. 14:1797-1809(2000) [PubMed: 10898794] [Abstract]
Cited for: INDUCTION.
[11]"CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53."
Hasan M.K., Yaguchi T., Sugihara T., Kumar P.K.R., Taira K., Reddel R.R., Kaul S.C., Wadhwa R.
J. Biol. Chem. 277:37765-37770(2002) [PubMed: 12154087] [Abstract]
Cited for: INTERACTION WITH CDKN2AIP.
[12]"p19ARF determines the balance between normal cell proliferation rate and apoptosis during mammary gland development."
Yi Y., Shepard A., Kittrell F., Mulac-Jericevic B., Medina D., Said T.K.
Mol. Biol. Cell 15:2302-2311(2004) [PubMed: 15105443] [Abstract]
Cited for: DEVELOPMENTAL STAGE, INDUCTION, DISRUPTION PHENOTYPE.
[13]"p19ARF directly and differentially controls the functions of c-Myc independently of p53."
Qi Y., Gregory M.A., Li Z., Brousal J.P., West K., Hann S.R.
Nature 431:712-717(2004) [PubMed: 15361884] [Abstract]
Cited for: FUNCTION, INTERACTION WITH MYC.
[14]"The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression."
Suzuki H., Kurita M., Mizumoto K., Moriyama M., Aiso S., Nishimoto I., Matsuoka M.
Biochem. Biophys. Res. Commun. 326:242-248(2005) [PubMed: 15567177] [Abstract]
Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH BCL6.
[15]"Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor."
Sreeramaneni R., Chaudhry A., McMahon M., Sherr C.J., Inoue K.
Mol. Cell. Biol. 25:220-232(2005) [PubMed: 15601844] [Abstract]
Cited for: FUNCTION, SUBCELLULAR LOCATION, INDUCTION.
[16]"Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer."
Mallakin A., Sugiyama T., Taneja P., Matise L.A., Frazier D.P., Choudhary M., Hawkins G.A., D'Agostino R.B. Jr., Willingham M.C., Inoue K.
Cancer Cell 12:381-394(2007) [PubMed: 17936562] [Abstract]
Cited for: FUNCTION.
[17]"A novel nuclear interactor of ARF and MDM2 (NIAM) that maintains chromosomal stability."
Tompkins V.S., Hagen J., Frazier A.A., Lushnikova T., Fitzgerald M.P., di Tommaso A.D., Ladeveze V., Domann F.E., Eischen C.M., Quelle D.E.
J. Biol. Chem. 282:1322-1333(2007) [PubMed: 17110379] [Abstract]
Cited for: INTERACTION WITH TBRG1.
[18]"Repression of Dmp1 and Arf transcription by anthracyclins: critical roles of the NF-kappaB subunit p65."
Taneja P., Mallakin A., Matise L.A., Frazier D.P., Choudhary M., Inoue K.
Oncogene 26:7457-7466(2007) [PubMed: 17546045] [Abstract]
Cited for: INDUCTION.
[19]"Solution structure of the p53 regulatory domain of the p19Arf tumor suppressor protein."
DiGiammarino E.L., Filippov I., Weber J.D., Bothner B., Kriwacki R.W.
Biochemistry 40:2379-2386(2001) [PubMed: 11327858] [Abstract]
Cited for: STRUCTURE BY NMR OF 1-37.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
L76092 mRNA. Translation: AAC42080.1.
BC058190 mRNA. Translation: AAH58190.3.
S80650 mRNA. Translation: AAB35770.1.
AJ238890 Genomic DNA. Translation: CAB65598.1.
U49281 Genomic DNA. Translation: AAC00053.1.
U49282 Genomic DNA. Translation: AAC00054.1.
AF120108 Genomic DNA. Translation: AAD33245.1.
IPIIPI00133446.
RefSeqNP_034007.1.
UniGeneMm.4733

3D structure databases

PDBe
RCSB PDB
PDBj
EntryMethodResolution (Å)ChainPositionsPDBsum
1HN3NMR-A1-37[»]
DisProtDP00335.
ModBaseSearch...

Protein-protein interaction databases

DIPDIP-24169N.
IntActQ64364. 4 interactions.
STRINGQ64364.

Proteomic databases

PRIDEQ64364.

Genome annotation databases

EnsemblENSMUST00000030237; ENSMUSP00000030237; ENSMUSG00000044303; Mus musculus. [Genome view]
GeneID12578.
UCSCuc008toi.1. mouse.

Organism-specific databases

CTD12578.
MGIMGI:104738. Cdkn2a.

Phylogenomic databases

HOVERGENQ64364.
InParanoidQ64364.
OrthoDBEOG9N5ZK9.

Gene expression databases

ArrayExpressQ64364.
BgeeQ64364.
CleanExMM_CDKN2A.
GenevestigatorQ64364.
GermOnlineENSMUSG00000044303. Mus musculus.

Family and domain databases

InterProIPR010868. P19Arf_N.
[Graphical view]
PANTHERPTHR21414. P19Arf_N. 1 hit.
PfamPF07392. P19Arf_N. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio281698.
SOURCESearch...

Entry information

Entry nameCD2A2_MOUSE
AccessionPrimary (citable) accession number: Q64364
Secondary accession number(s): Q4U255, Q9QXC7, Q9R051
Entry history
Integrated into UniProtKB/Swiss-Prot: October 11, 2005
Last sequence update: November 1, 1996
Last modified: December 15, 2009
This is version 74 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)

Relevant documents

MGD cross-references

Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents